Advisory Boards

We provide expert advice to companies on their proposed pricing, market access and evidence generation strategies.

access expert advice
from industry experts

Whether it be on the optimal comparator for a clinical trial, which endpoints should be included, or advice on what real-world evidence to generate to meet payers’ needs, Oncology Access Solutions has the capabilities to best support your needs.

With a focus on patients, we promote the importance of engaging with patient advocacy groups, HTA agencies and regulators to elicit feedback and validate evidence generation plans ahead of launch

$375bnexpected spending total on cancer medicines by 2027

5%global increase number of treated patients over the past five years

2,000oncology products currently under development

a consultancy you can trust

we are  
industry experts

we are
dedicated

we are
patient-centric

a wealth of life science
knowledge and expertise

Oncology Access Solutions Ltd is led and founded by Dr Clare Hague – a highly experienced health economist and health services researcher with a strong industry and academic background.

With over 18 years of industry experience with large, mid-sized and start-up biotech companies, we Clare is a seasoned and knowledgeable independent consultant able to provide a discreet and dedicated service.

Learn more